CS logo
small CS logo
Toyonaka Keijinkai Clinic

Toyonaka, Osaka, Japan
General hospital in Toyonaka
1 Chome-8-12 Shoji, Toyonaka, Osaka 560-0004

About Toyonaka Keijinkai Clinic


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Toyonaka Keijinkai Clinic


During the past decade, Toyonaka Keijinkai Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Secondary Prevention of Small Subcortical Strokes Trial
2003-02-01
2012-04-01
Completed
3,020
Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis
2000-05-01
2002-12-01
Completed
300
"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
2005-01-01
2007-05-01
Completed
200
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925

Rows per page:

1–100 of 652

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Toyonaka Keijinkai Clinic


According to Clinical.Site data, the most researched conditions in "Toyonaka Keijinkai Clinic" are "Anemia" (2 trials) and "Renal Insufficiency, Chronic" (2 trials). Many other conditions were trialed in "Toyonaka Keijinkai Clinic" in a lesser frequency.

Clinical Trials Intervention Types at Toyonaka Keijinkai Clinic


Most popular intervention types in "Toyonaka Keijinkai Clinic" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Molidustat (BAY85-3934)" (2 trials), "Darbepoetin alfa" (1 trials), "Placebo of Darbepoetin alfa" (1 trials) and "Placebo of Molidustat (BAY85-3934)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Toyonaka Keijinkai Clinic


The vast majority of trials in "Toyonaka Keijinkai Clinic" are 2 trials for "All" genders.

Clinical Trials Status at Toyonaka Keijinkai Clinic


Currently, there are NaN active trials in "Toyonaka Keijinkai Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Toyonaka Keijinkai Clinic, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Toyonaka Keijinkai Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status